Prelude Therapeutics Inc (PRLD) Insider Trading
- $5,241,823.19
- $7,511,453.10
- May 24, 2023
- David J Mauro
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| May 24, 2023 | CEO | 1,000 | $5.01 | Buy | $5,010.00 | |
| May 22, 2023 | Director | 869,565 | $5.75 | Buy | $4,999,998.75 | |
| April 6, 2023 | CMO | 13,280 | $6.12 | Sell | $81,273.60 | |
| Dec. 20, 2022 | CEO | 19,188 | $5.13 | Buy | $98,434.44 | |
| Dec. 8, 2022 | CFO | 10,000 | $4.76 | Buy | $47,600.00 | |
| June 1, 2022 | CFO | 10,000 | $4.23 | Buy | $42,300.00 | |
| Dec. 13, 2021 | EVP | 4,000 | $12.12 | Buy | $48,480.00 | |
| Nov. 16, 2021 | EVP | 28,751 | $15.88 | Sell | $456,565.88 | |
| Oct. 5, 2021 | Insider | 15,000 | $30.96 | Sell | $464,400.00 | |
| Sept. 7, 2021 | Insider | 15,000 | $36.69 | Sell | $550,350.00 | |
| Sept. 2, 2021 | EVP | 17,000 | $41.68 | Sell | $708,560.00 | |
| Aug. 26, 2021 | Insider | 1,700 | $35.19 | Sell | $59,823.00 | |
| Aug. 25, 2021 | CFO | 8,333 | $33.34 | Sell | $277,822.22 | |
| Aug. 5, 2021 | Insider | 15,000 | $31.09 | Sell | $466,350.00 | |
| July 27, 2021 | Insider | 20,000 | $35.47 | Sell | $709,400.00 | |
| July 6, 2021 | Insider | 15,000 | $27.47 | Sell | $412,050.00 | |
| June 7, 2021 | Insider | 15,000 | $32.44 | Sell | $486,600.00 | |
| May 25, 2021 | CFO | 8,333 | $34.27 | Sell | $285,571.91 | |
| May 7, 2021 | Insider | 10,000 | $40.82 | Sell | $408,200.00 | |
| May 5, 2021 | Insider | 15,000 | $40.14 | Sell | $602,100.00 | |
| April 29, 2021 | EVP | 3,295 | $40.29 | Sell | $132,755.55 | |
| April 19, 2021 | Insider | 25,000 | $30.89 | Sell | $772,250.00 | |
| April 7, 2021 | insider | 15,370 | $39.31 | Sell | $604,194.70 | |
| April 7, 2021 | EVP | 828 | $40.08 | Sell | $33,186.24 |
Insiders are both buying and selling Prelude Therapeutics Inc stock.
The insider traders at Prelude Therapeutics Inc are: David J Mauro, Peggy Scherle, Christopher Pierce, Krishna Vaddi, Laurent Chardonnet, Brian Piper, Deborah Morosini, David J. Mauro, Andrew Combs, Jane Huang, and Orbimed Advisors Llc
The most active insider trader at Prelude Therapeutics Inc is David J Mauro with 6 trades.
David J Mauro has sold the most Prelude Therapeutics Inc stock with a total value of $3,806,450.00.
Orbimed Advisors Llc has bought the most Prelude Therapeutics Inc stock with a total value of $9,999,997.50.
The most recent insider trade for Prelude Therapeutics Inc was on May 24, 2023.
The single biggest insider buy for Prelude Therapeutics Inc was from Orbimed Advisors Llc with a total value of $4,999,998.75 on May 22, 2023.
The single biggest insider sell for Prelude Therapeutics Inc was from David J Mauro with a total value of $772,250.00 on April 19, 2021.